한글목차

주사 치료 동향과 예측

세계의 주사 치료 시장은 2024년부터 2030년까지 CAGR 7.8%로, 2030년까지 약 31억 6,000만 달러에 달할 것으로 예상됩니다. 이 시장의 주요 성장 촉진요인은 주사 발증률과 유병률 상승과 병용요법, 병용 제품 경향 확대 및 고령자 수 증가입니다. 세계의 주사 치료 시장의 미래는 항생제, 알파 작용제, 레티노이드, 코르티코스테로이드, 면역억제제, 항고혈압제 시장에서 기회가 있어 유망해 보입니다.

주사 치료 시장에 관한 인사이트

Lucintel은 토픽은 예측기간 중 가장 높은 성장을 이룰 것으로 예상하고 있습니다.

북미는 소비자 지식 확대, 신약 개발, 정확한 진단을 위한 기술 개발에 의해 예측기간 동안 가장 높은 성장을 이룰 것으로 예상됩니다.

자주 묻는 질문

Q1. 주사 치료 시장 규모는 어느 정도인가?

A1. 세계의 주사 치료 시장은 2030년까지 약 31억 6,000만 달러에 달할 것으로 예상됩니다.

Q2. 주사 치료 시장 성장 예측은 무엇인가?

A2. 세계의 주사 치료 시장은 2024년부터 2030년까지 7.8%의 CAGR로 성장할 것으로 예상됩니다.

Q3. 주사 치료 시장의 성장에 영향을 미치는 주요 요인은 무엇인가?

A3. 이 시장의 주요 성장 촉진요인은 주사 발생률과 병용요법 유병률 상승, 병용 제품 경향 증대 및 고령자 수 증가입니다.

Q4. 시장의 주요 부문은?

A4. 주사 치료 시장의 미래는 항생제, 알파 작용제, 레티노이드, 코르티코스테로이드, 면역억제제, 항고혈압제 시장에서 기회가 있어 유망해 보입니다.

Q5. 시장의 주요 기업은?

A5. 주요 주사 치료 회사는 다음과 같습니다.

• Galderma
• Allergan
• Bayer
• Bausch Health Companie
• Leo Pharma
• Sol-Gel Technologies
• Foamix Pharmaceuticals
• Aclaris Therapeutics
• Anaptysbio

Q6. 향후 최대가 되는 시장 부문은?

A6. Lucintel은 토픽은 예측기간 중 가장 높은 성장을 이룰 것으로 예상하고 있습니다.

Q7. 시장에서 향후 5년 동안 최대가 될 것으로 예상되는 지역은?

A7. 북미는 소비자 지식 확대, 신약 개발, 정확한 진단을 위한 기술 개발에 의해 예측기간 동안 가장 높은 성장을 이룰 것으로 예상됩니다.

Q8. 보고서 커스터마이징이 가능한가?

A8. 네, Lucintel은 추가 비용 없이 10% 커스터마이징을 제공합니다.

목차

제1장 주요 요약

제2장 세계의 주사 치료 시장 : 시장 역학

• 서론, 배경, 분류
• 공급망
• 업계 성장 촉진요인과 과제

제3장 2018년부터 2030년까지 시장 동향과 예측 분석

• 거시경제 동향(2018-2023년)과 예측(2024-2030년)
• 세계의 주사 치료 시장 동향(2018-2023년)과 예측(2024-2030년)
• 약제 클래스별 세계의 주사 치료 시장
  • 항생제
  • 알파 작용제
  • 레티노이드
  • 코르티코스테로이드
  • 면역억제제
  • 항고혈압제
  • 기타
• 투여 방법별 세계의 주사 치료 시장
  • 외용
  • 경구

제4장 2018년부터 2030년까지 지역별 시장 동향과 예측 분석

• 지역별 세계의 주사 치료 시장
• 북미의 주사 치료 시장
• 유럽의 주사 치료 시장
• 아시아태평양의 주사 치료 시장
• 기타 지역의 주사 치료 시장

제5장 경쟁 분석

• 제품 포트폴리오 분석
• 운영상 통합
• Porter's Five Forces 분석

제6장 성장 기회와 전략적 분석

• 성장 기회 분석
  • 약제 클래스별 세계의 주사 치료 시장 성장 기회
  • 투여 방법별 세계의 주사 치료 시장 성장 기회
  • 지역별 세계의 주사 치료 시장 성장 기회
• 세계의 주사 치료 시장 최신 동향
• 전략적 분석
  • 신제품 개발
  • 세계의 주사 치료 시장 능력 확대
  • 세계의 주사 치료 시장 합병, 인수, 합작투자
  • 인증과 라이선싱

제7장 유력 기업의 기업 개요

• Galderma
• Allergan
• Bayer
• Bausch Health Companie
• Leo Pharma
• Sol-Gel Technologies
• Foamix Pharmaceuticals
• Aclaris Therapeutics
• AnaptysBio

영문목차

Rosacea Treatment Trends and Forecast

The future of the global rosacea treatment market looks promising with opportunities in the antibiotics, alpha agonists, retinoids, corticosteroids, immunosuppressants, and antihypertensive agents markets. The global rosacea treatment market is expected to reach an estimated $3.16 billion by 2030 with a CAGR of 7.8% from 2024 to 2030. The major drivers for this market are rising rosacea incidence and prevalence combination therapies, growing the tendency for combination products, and growing number of elderly people.

A more than 150-page report is developed to help in your business decisions.

Rosacea Treatment by Segment

The study includes a forecast for the global rosacea treatment by drug class, mode of administration and region.

Rosacea Treatment Market by Drug Class [Shipment Analysis by Value from 2018 to 2030]:

• Antibiotics
• Alpha agonists
• Retinoids
• Corticosteroids
• Immunosuppressants
• Antihypertensive Agents
• Others

Rosacea Treatment Market by Mode of Administration [Shipment Analysis by Value from 2018 to 2030]:

• Topical
• Oral

Rosacea Treatment Market by Region [Shipment Analysis by Value from 2018 to 2030]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

List of Rosacea Treatment Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies rosacea treatment companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the rosacea treatment companies profiled in this report include-

• Galderma
• Allergan
• Bayer
• Bausch Health Companie
• Leo Pharma
• Sol-Gel Technologies
• Foamix Pharmaceuticals
• Aclaris Therapeutics
• Anaptysbio

Galderma, Allergan, Bayer, Bausch Health Companies, Leo Pharma, Sol-Gel Technologies, Foamix Pharmaceuticals, Aclaris Therapeutics, and AnaptysBio are the major suppliers in the rosacea treatment market.

Rosacea Treatment Market Insights

Lucintel forecasts that topical is expected to witness highest growth over the forecast period.

North America is expected to witness highest growth over the forecast period due to expanding consumer knowledge, the creation of new medications, and technical developments for precise diagnosis.

Features of the Global Rosacea Treatment Market

Market Size Estimates: Rosacea treatment market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Rosacea treatment market size by drug class, mode of administration, and region in terms of value ($B).

Regional Analysis: Rosacea treatment market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different drug class, mode of administration, and regions for the rosacea treatment market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the rosacea treatment market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1 What is the rosacea treatment market size?

Answer: The global rosacea treatment market is expected to reach an estimated $3.16 billion by 2030.

Q.2 What is the growth forecast for rosacea treatment market?

Answer: The global rosacea treatment market is expected to grow with a CAGR of 7.8% from 2024 to 2030.

Q.3 What are the major drivers influencing the growth of the rosacea treatment market?

Answer: The major drivers for this market are rising rosacea incidence and prevalence combination therapies, growing the tendency for combination products, and growing number of elderly people.

Q4. What are the major segments for rosacea treatment market?

Answer: The future of the rosacea treatment market looks promising with opportunities in the antibiotics, alpha agonists, retinoids, corticosteroids, immunosuppressants, and antihypertensive agents markets.

Q5. Who are the key Rosacea Treatment Market companies?

Answer: Some of the key rosacea treatment companies are as follows.

• Galderma
• Allergan
• Bayer
• Bausch Health Companie
• Leo Pharma
• Sol-Gel Technologies
• Foamix Pharmaceuticals
• Aclaris Therapeutics
• Anaptysbio

Q6. Which rosacea treatment market segment will be the largest in future?

Answer: Lucintel forecasts that topical is expected to witness highest growth over the forecast period.

Q7. In rosacea treatment market, which region is expected to be the largest in next 5 years?

Answer: North America is expected to witness highest growth over the forecast period due to expanding consumer knowledge, the creation of new medications, and technical developments for precise diagnosis.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the rosacea treatment market by drug class (antibiotics, alpha agonists, retinoids,corticosteroids, immunosuppressants, antihypertensive agents, and others), mode of administration (topical and oral), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Rosacea Treatment Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

• 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
• 3.2. Global Rosacea Treatment Market Trends (2018-2023) and Forecast (2024-2030)
• 3.3: Global Rosacea Treatment Market by Drug Class
  • 3.3.1: Antibiotics
  • 3.3.2: Alpha agonists
  • 3.3.3: Retinoids
  • 3.3.4: Corticosteroids
  • 3.3.5: Immunosuppressants
  • 3.3.6: Antihypertensive Agents
  • 3.3.7: Others
• 3.4: Global Rosacea Treatment Market by Mode of Administration
  • 3.4.1: Topical
  • 3.4.2: Oral

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

• 4.1: Global Rosacea Treatment Market by Region
• 4.2: North American Rosacea Treatment Market
  • 4.2.2: North American Rosacea Treatment Market by Mode of Administration: Topical and Oral
• 4.3: European Rosacea Treatment Market
  • 4.3.1: European Rosacea Treatment Market by Drug Class : Antibiotics, Alpha agonists, Retinoids, Corticosteroids, Immunosuppressants, Antihypertensive Agents, and Others
  • 4.3.2: European Rosacea Treatment Market by Mode of Administration: Topical and Oral
• 4.4: APAC Rosacea Treatment Market
  • 4.4.1: APAC Rosacea Treatment Market by Drug Class : Antibiotics, Alpha agonists, Retinoids, Corticosteroids, Immunosuppressants, Antihypertensive Agents, and Others
  • 4.4.2: APAC Rosacea Treatment Market by Mode of Administration: Topical and Oral
• 4.5: ROW Rosacea Treatment Market
  • 4.5.1: ROW Rosacea Treatment Market by Drug Class: Antibiotics, Alpha agonists, Retinoids,Corticosteroids,Immunosuppressants,Antihypertensive Agents, and Others
  • 4.5.2: ROW Rosacea Treatment Market by Mode of Administration: Topical and Oral

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Rosacea Treatment Market by Drug Class
  • 6.1.2: Growth Opportunities for the Global Rosacea Treatment Market by Mode of Administration
  • 6.1.3: Growth Opportunities for the Global Rosacea Treatment Market by Region
• 6.2: Emerging Trends in the Global Rosacea Treatment Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Rosacea Treatment Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Rosacea Treatment Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: Galderma
• 7.2: Allergan
• 7.3: Bayer
• 7.4: Bausch Health Companie
• 7.5: Leo Pharma
• 7.6: Sol-Gel Technologies
• 7.7: Foamix Pharmaceuticals
• 7.8: Aclaris Therapeutics
• 7.9: AnaptysBio